| Previous Section | Index | Home Page |
Body Dysmorphic Disorder
Mr. Gordon Prentice: To ask the Secretary of State for Health what estimate has had made of the number of people who suffer from body dysmorphic disorder; and if he will make a statement. [109680]
Mr. Denham: The number of reported admissions to National Health Service hospitals in England with a diagnosis of body dysmorphic disorder during the financial year 1997-98 was 121.
NHS Dentistry (Shropshire)
Mr. Gill: To ask the Secretary of State for Health what assessment he has made of the adequacy of provision of NHS dentistry in Shropshire; and if he will make a statement. [109829]
Mr. Hutton: National Health Service Dental Services are accessible for much of the population of Shropshire, although I am aware that in some areas, there are longstanding problems of availability of NHS Dentistry. Shropshire Health Authority, through its Health Improvement Programme for 2000-01, has taken steps to enhance registration opportunities. These include a pilot for a Dental Access Centre, where services are offered to non-registered patients, as well as a number of "Investing in Dentistry" initiatives.
NICE
Mrs. Gillan: To ask the Secretary of State for Health (1) if he will publish the relevant interests declared by (a) members of the Appraisal Committee of NICE and (b) specialist advisers appointed in respect of each evaluation commissioned by NICE since its establishment; [109703]
- (2) if he will list the names and qualifications of the members of the Appraisal Committee of the National Institute for Clinical Excellence; [109701]
(3) when the specialist advisers who will be called upon to provide evidence to NICE on beta interferon will be appointed; and how many will be appointed. [109702]
Mr. Denham
[holding answer 11 February 2000]: The National Institute for Clinical Excellence, subject to the approval of the Secretary of State, is responsible for
29 Feb 2000 : Column: 227W
deciding the members of their Appraisal Committee. NICE operates in an open and transparent way, and the list of members and interests for the Appraisal Committee will be placed in the Library, or can be found on NICE's website at www.nice.org.uk. NICE will also be publishing the names and interests of its specialist advisers when the appraisal committee has met, and any interests of Appraisal Committee members will also be recorded in the Minutes of the Appraisal Board meetings. The appraisal on beta-interferon is scheduled for August this year. The specialist advisers for beta-interferon will be appointed shortly, and their appointments will be available in the Library or on the NICE website.
The members of the NICE appraisal Committee are:
Mr. Paul Marsden:
To ask the Secretary of State for Health when he expects NHS Direct to cover (a) Shrewsbury and Atcham and (b) Shropshire; and if he will make a statement. [110134]
Ms Stuart:
NHS Direct will be available to the whole of England, including Shrewsbury and Atcham and Shropshire, by the end of October 2000.
Mr. Robertson:
To ask the Secretary of State for Health what is the average price inflation of drugs supplied to the NHS for each of the last 10 years for which figures are available; and if he will make a statement. [110558]
Ms Stuart:
Information on the average price increase over previous year's prices is given in the table. It covers all prescriptions dispensed in the community in England.
29 Feb 2000 : Column: 228W
Professor David Barnett
Professor Ronald Akehurst
Professor Sir Colin Berry
Professor Martin Buxby
Professor Yvonne Carter
Dr. Karl Claxton
Professor Duncan Colin-Jones
Professor Sarah Cowley
Dr. Nicki Cullum
Mr. Christopher Evennett
Ms Jean Gaffin
Dr. Trevor Gibbs
Dr. Sheila Gore
Mr. John Goulston
Professor Philip Home
Dr. Terry John
Dr. Diane Ketley
Mr. Mayur Lakhani
Mr. Muntzer Mughal
Mr. James Partridge
Dr. Linda Patterson
Professor Philip Routledge
Professor Andrew Stevens
Mrs. Sue Gallagher.
| Percentage increase | |
|---|---|
| 1993 | -3.2 |
| 1994 | -1.7 |
| 1995 | -1.3 |
| 1996 | 0.0 |
| 1997 | -0.4 |
| 1998 | -2.6 |
Notes:
1. The table has been composed using the Paasche index, which gives the percentage change in the average price of products which existed in both years.
2. Data is only available from 1992 onwards.
Mr. Robertson: To ask the Secretary of State for Health how much money is provided by drug companies to the NHS; what form these donations take; which companies provide the major contributions; and if he will make a statement. [110556]
Ms Stuart: The Department expects all significant donations to be declared at local level, as set out in existing guidelines published in January 1993--Standards of business conduct for National Health Service staff (HSG(93)5).
Consultation has recently taken place on updated guidance, which we expect to be available shortly.
Mr. Robertson:
To ask the Secretary of State for Health which EU regulations govern the pricing and supply of drugs; and if he will make a statement. [111468]
Ms Stuart:
The pricing and supply of medicines are not governed directly by EU regulations, but left to member states. However the measures adopted by member states have to conform to the general requirements of European law and in particular Council Directive 89/105/EEC relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems.
Mr. Robertson:
To ask the Secretary of State for Health if he will make a statement on the NHS's purchasing policy for (a) generic and (b) branded drugs. [111469]
Ms Stuart:
Our policy is to secure purchasing arrangements which ensure a reliable and secure supply of medicines to patients and value for money for the National Health Service.
In the case of branded medicines, we have negotiated a new five-year Pharmaceutical Price Regulation Scheme (PPRS). The PPRS includes a 4.5 per cent. reduction in the price of branded medicines from October 1999. Thereafter, the only changes permitted until 1 January 2001 are cost-neutral modulations, with strict controls on price increases after that date. The Health Act 1999 includes reserve powers to deal with companies that elect not to be scheme members or cease to be scheme members. Regulations came into force on 14 February 2000 to ensure that the prices of medicines supplied by
29 Feb 2000 : Column: 229W
companies outside the voluntary scheme may be controlled, and the price reduction implemented where appropriate. At the same time the PPRS contains incentives to companies to develop new medicines, and allowances for the cost of research and development.
Generic medicines are not covered by the PPRS. We have commissioned a fundamental review of arrangements for the supply of generic medicines to the NHS in England to examine whether existing arrangements best serve the health service and to identify possible alternatives. The conclusions of the programme of work are expected in the summer.
The NHS Supplies Authority plays a part in the procurement of medicines for hospitals. The NHS Purchasing and Supply Agency will be set up from 1 April to improve the efficiency and effectiveness of purchasing in the NHS in England.
Dr. Brand:
To ask the Secretary of State for Health how many surgical interventions for epilepsy have been carried out in each region in each of the last 10 years. [110933]
29 Feb 2000 : Column: 230W
Mr. Hutton:
The Information requested has been placed in the Library.
Mr. Hinchliffe:
To ask the Secretary of State for Health to ask the Secretary of State for Health when the report of the Clinical Standards Advisory Group on epilepsy will be published. [111504]
Mr. Hutton:
We are currently considering the report's conclusions and recommendations and their implications for the National Health Service. The report will be published in the near future.
Mr. Hinchliffe:
To ask the Secretary of State for Health what plans he has for changes to NHS services for people with epilepsy. [111505]
Mr. Hutton:
When we have published the report from the Clinical Standards Advisory Group on epilepsy, officials will meet with members of the Joint Epilepsy Council to carry work on epilepsy services forward.
Mrs. Dean:
To ask the Secretary of State for Health how many general practitioners have been (a) struck off and (b) reprimanded for professional negligence in each year since 1995. [110790]
Mr. Denham:
The information requested is contained in the table:
29 Feb 2000 : Column: 229W
| Year | Erased from the medical register | Suspended from the medical register | Admonished (15) | Conditions on registration | Referred to health committee |
|---|---|---|---|---|---|
| 1995 | 8 | 4 | 6 | 2 | -- |
| 1996 | 12 | 5 | 4 | 9 | -- |
| 1997 | 7 | 5 | 6 | 2 | -- |
| 1998 | 10 | 1 | 7 | -- | -- |
| 1999 | 28 | 3 | 2 | 7 | 2 |
| Jan 2000 | 4 | 1 | 2 | 1 | -- |
| Total | 69 | 19 | 27 | 21 | 2 |
(15) Found guilty of serious professional misconduct but have no restrictions placed on registration.
Source:
General Medical Council statistics on erasures and other sanctions imposed on general practioners by the Professional Conduct Committee.
29 Feb 2000 : Column: 229W
| Next Section | Index | Home Page |